PubMed laboratory research record [PMID: 41494820] PubMed record related to this compound for laboratory literature review
Retatrutide is making headlines before its even approved because it works differently from currently available weight-loss medications
Namely, research suggests a link between the risk of gallbladder issues, including gallstones, and longer treatment durations (over 26 weeks)
For anyone already optimizing their hormonal environment, whether through lifestyle practices or exogenous support, this is a meaningful synergy
Under these conditions, the increased secretion of counterregulatory hormones stimulates FFAs oxidation in the liver and accelerates the production of ketone bodies, which are metabolized in muscle, adipose tissue and, most importantly, in heart and brain (52)